Paula and Rodger Riney Foundation

EIN 823268996

St Louis, MO 63141 |(314) 552-6022

https://WWW.PAULAANDRODGERRINEYFOUNDATION.ORG
Total Given 2018–2024
$129.1M
71 grants · $18.4M avg/year
based on 7 yrs of IRS 990-PF records on file
$10M+/yr
major funder
capacity
$100K
typical big bets · $5K–$3.0M
grant size
14%
transactional · 8/57 multi-year
repeat
$149.7M
Assets (2024)
57
Distinct Recipients

About

THE FOUNDATION'S START-UP PERIOD IS 2018-2021. AS OF 12/31/20, THE FOUNDATION'S START-UP PERIOD DISTRIBUTABLE AND MINIMUM AMOUNTS WERE: 2018 $ 890,859 X 20% = $ 178,172 2019 $8,200,014 X 40% = $ 3,280,006 2020 $8,108,508 X 60% = $ 4,865,105 2021 $6,917,393 X 80% = $ 5,533,914 (PER ON 2020 990PF) TOTAL $13,857,197START-UP PERIOD MINIMUM AMOUNTS MUST BE DISTRIBUTED BEFORE THE END OF THE START-UP PERIOD, BUT THERE IS NOT A REQUREIMENT THAT ANY PORTION OF SUCH AMOUNT BE DISTRIBUTED IN ANY ONE TAXABLE YEAR OF THE START-UP PERIOD. THE FOUNDATION'S ACTUAL PAYMENTS MADE IN CASH FOR EXEMPT PURPOSES DURING THE START-UP PERIOD ARE AS FOLLOWS: 2018 $ 1,017,000 2019 $ 9,045,023 2020 $ 5,642,045 TOTAL $15,704,068 THE FOUNDATION'S ACTUAL DISTRIBUTED AMOUNT EXCEEDS THE START-UP PERIOD MINIMUM AMOUNT. TREAS. REG. 53.4942(A)-3(B)(3) AND (4) PROVIDE THE CASH-DISTRIBUTION TEST AND START-UP PERIOD GUIDANCE, RESPECTIVELY. THE FOUNDATION HAS MET THE ACTUAL DISTRIBUTION REQUIREMENT FOR THE START-UP PERIOD. THE FOUNDATION DESIRES TO FUND A PROJECT WHICH WILL FURTHER RESEARCH IN, ADVANCE THE SEARCH FOR CURES FOR, AND ENHANCE THE PREVENTION OF MULTIPLE MYELOMA. THE SPECIFIC PROJECT WOULD NOT BE COMPLETED BY THE END OF THE TAXABLE YEAR IN WHICH THE SET-ASIDE WAS TO BE MADE (2020). THE AMOUNT SET-ASIDE FOR THIS PROJECT IS ANTICIPATED TO BE ACTUALLY PAID WITHIN A TWELVE MONTH PERIOD, BUT NO MORE THAN 60 MONTHS AFTER THE DATE OF THE SET-ASIDE.

Focus Areas

Health

Application Information

Accepts Unsolicited Proposals No — Preselected Only
Phone (314) 552-6022

Financial Trends

Giving Over Time

Total Assets Over Time

View financial data as table
YearTotal GivingTotal AssetsRevenueGrants
2018 $1.0M $163.1M $2.2M 19
2019 N/A $171.9M $3.8M N/A
2020 $5.0M $212.6M $3.5M 3
2021 $17.2M $228.3M $1.8M 4
2022 $30.7M $166.4M $17.5M 6
2023 $42.5M $154.5M $23.9M 25
2024 $32.7M $149.7M $3.2M 14

Grant Size Distribution

Based on 71 grants on record

Minimum
$120
25th Pctl
$5K
Median
$100K
Average
$1.8M
75th Pctl
$3.0M
Maximum
$16.0M

Geographic Distribution

Officers & Directors

Grants Awarded (71 total)

Purpose
Dana Farber Cancer Institute Boston, MA $16,000,000 ADVANCE TREATMENT, CURE AND PREVENTION OF CANCER AND RELATED DISEASES 2022
Dana Farber Cancer Institute Boston, MA $13,527,778 ADVANCE TREATMENT, CURE AND PREVENTION OF CANCER AND RELATED DISEASES 2023
Dana Farber Cancer Institute Boston, MA $12,000,000 ADVANCE TREATMENT, CURE AND PREVENTION OF CANCER AND RELATED DISEASES 2024
Inserm Paris Cedex, None $5,150,000 ADVANCE TREATMENT, CURE AND PREVENTION OF CANCER AND RELATED DISEASES 2021
Centre Hospitalier Universitaire De Toulouse Toulouse, None $5,150,000 ADVANCE TREATMENT, CURE AND PREVENTION OF CANCER AND RELATED DISEASES 2024
University of Wurzburg Wurzberg, None $5,139,720 ADVANCE TREATMENT, CURE AND PREVENTION OF CANCER AND RELATED DISEASES 2023
Dana Farber Cancer Institute Boston, MA $5,100,000 ADVANCE TREATMENT, CURE AND PREVENTION OF CANCER AND RELATED DISEASES 2021
Dana Farber Cancer Institute Boston, MA $5,000,000 ADVANCE TREATMENT, CURE, AND PREVENTION OF CANCER AND RELATED DISEASES 2020
University of Missouri Columbia, MO $4,110,826 ADVANCE TREATMENT, CURE AND PREVENTION OF CANCER AND RELATED DISEASES 2024
St Louis Community Foundation St Louis, MO $4,100,000 PLEASE SEE PART XIV 3A FOR THE PURPOSE OF THE CONTRIBUTIONTHE CURRENT YEAR CONTRIBUTION WAS PROVIDED TO ADMINISTER... 2023
University of Navarra Pamplona, None $3,537,000 ADVANCE TREATMENT, CURE AND PREVENTION OF CANCER AND RELATED DISEASES 2021
American Friends of Uhn Toronto, None $3,481,965 ADVANCE TREATMENT, CURE AND PREVENTION OF CANCER AND RELATED DISEASES 2022
Princess Margarate Cancer Foundation (University Health Network) Toronto, None $3,481,964 ADVANCE TREATMENT, CURE AND PREVENTION OF CANCER AND RELATED DISEASES 2023
International Myeloma Society Rochester, MN $3,426,527 ADVANCE TREATMENT, CURE AND PREVENTION OF CANCER AND RELATED DISEASES 2021
International Myeloma Society Needham, MA $3,366,379 ADVANCE TREATMENT, CURE AND PREVENTION OF CANCER AND RELATED DISEASES 2023
International Myeloma Society Needham, MA $3,243,663 ADVANCE TREATMENT, CURE AND PREVENTION OF CANCER AND RELATED DISEASES 2022
International Myeloma Society Boston, MA $3,139,644 ADVANCE TREATMENT, CURE AND PREVENTION OF CANCER AND RELATED DISEASES 2024
Massachusetts General Hospital Boston, MA $2,991,261 ADVANCE TREATMENT, CURE AND PREVENTION OF CANCER AND RELATED DISEASES 2023
The Medical College of Wisconsin Milwaukee, WI $2,982,559 ADVANCE TREATMENT, CURE AND PREVENTION OF CANCER AND RELATED DISEASES 2022
The Medical College of Wisconsin Milwaukee, WI $2,982,559 ADVANCE TREATMENT, CURE AND PREVENTION OF CANCER AND RELATED DISEASES 2023
Massachusetts General Hospital Boston, MA $2,813,974 ADVANCE TREATMENT, CURE AND PREVENTION OF CANCER AND RELATED DISEASES 2022
Purdue University West Lafayette, IN $2,131,435 ADVANCE TREATMENT, CURE AND PREVENTION OF CANCER AND RELATED DISEASES 2022
Purdue University West Lafayette, IN $2,131,435 ADVANCE TREATMENT, CURE AND PREVENTION OF CANCER AND RELATED DISEASES 2023
Mayo Clinic Rochester, MN $2,019,000 ADVANCE TREATMENT, CURE AND PREVENTION OF CANCER AND RELATED DISEASES 2024
Ohio State University Comprehensive Cancer Center Columbus, OH $2,000,000 ADVANCE TREATMENT, CURE AND PREVENTION OF CANCER AND RELATED DISEASES 2023